Atara Biotherapeutics Balance Sheet (2022-2025) | ATRA

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 101.67M70.69M65.11M92.94M48.74M45.90M64.79M25.84M35.09M31.31M46.45M25.03M13.84M16.90M5.74M
Short-term Investments 200.14M260.62M200.29M149.88M156.67M107.74M37.62M25.88M11.15M3.98M20.74M17.47M0.15M5.42M7.97M
Cash & Current Investments 301.81M331.31M265.40M242.82M205.41M153.64M102.41M51.73M46.24M35.29M67.19M42.50M13.99M22.32M13.71M
Receivables - Net 0.67M0.64M0.25M40.22M0.40M0.51M0.16M34.11M35.83M2.42M1.33M1.48M8.88M1.91M
Receivables 0.67M0.64M0.25M40.22M0.40M0.51M0.16M34.11M35.83M2.42M1.33M1.48M8.88M1.91M
Raw Materials 1.21M1.32M2.75M2.42M2.33M4.36M3.64M1.65M0.96M
Work In Process 0.37M4.02M5.11M4.17M7.37M11.72M15.11M12.33M9.69M
Inventory 1.59M5.34M7.86M6.59M9.71M16.08M18.75M13.98M10.65M
Prepaid Assets 11.57M13.69M16.05M10.31M12.89M10.16M9.39M6.18M8.13M5.80M9.21M10.12M4.32M2.45M2.81M
Current Assets 314.39M346.98M283.05M295.08M224.18M172.32M118.70M101.87M106.43M62.41M91.86M64.89M27.18M24.77M18.43M
Non-Current Assets
Property, Plant & Equipment (Net) 9.11M8.33M7.27M6.30M5.85M5.35M4.63M3.86M2.99M2.32M1.66M1.29M0.28M0.18M0.15M
Other Non-Current Assets 51.43M7.23M7.17M7.02M6.91M6.58M6.29M4.84M3.87M3.61M3.36M3.10M2.84M0.93M0.88M
Non-Current Assets 82.89M89.14M85.27M81.34M77.90M74.12M70.09M63.63M58.84M54.87M50.85M44.20M34.86M12.13M11.73M
Assets 397.28M436.12M368.32M376.42M302.08M246.44M188.79M165.50M165.27M117.28M142.71M109.10M62.04M36.90M30.17M
Liabilities
Current Liabilities
Accounts Payables 11.95M12.80M11.30M6.87M5.07M4.14M6.51M3.68M2.85M5.25M2.15M4.37M1.38M1.76M0.32M
Payables 11.95M12.80M11.30M6.87M5.07M4.14M6.51M3.68M2.85M5.25M2.15M4.37M1.38M1.76M0.32M
Accumulated Expenses 16.38M16.32M17.61M17.66M8.91M12.56M14.43M19.01M18.20M11.19M8.06M6.59M9.50M4.78M2.55M
Other Accumulated Expenses 13.99M19.78M22.81M24.99M23.77M25.17M23.97M31.83M33.05M26.15M23.64M20.16M24.14M7.67M4.65M
Current Leases 12.81M11.78M12.10M12.41M11.26M13.09M13.02M13.65M12.88M12.85M2.24M1.95M
Current Deferred Revenue 50.94M1.67M2.66M85.00M9.92M11.95M11.61M77.83M123.15M107.58M116.34M95.09M15.98M1.61M1.01M
Total Current Liabilities 101.56M65.69M72.24M78.92M67.88M74.55M79.09M142.23M180.69M148.27M155.98M134.57M47.89M14.56M18.06M
Non-Current Liabilities
Non-Current Deffered Revenue 45.00M43.33M42.34M77.00M78.04M75.56M73.93M37.56M0.72M0.57M0.47M
Liabilities from Discontinued Operations 8.33M
Operating Leases 17.45M64.00M61.07M58.06M54.92M51.75M48.51M45.69M42.20M38.70M35.24M29.91M26.71M15.43M15.01M
Other Non-Current Liabilities 0.62M5.63M5.55M5.56M5.18M5.02M4.85M35.08M4.40M4.17M3.97M39.01M39.87M40.79M41.65M
Total Non-Current Liabilities 172.35M173.02M175.65M244.22M231.95M233.96M234.78M229.66M259.18M223.99M229.28M167.38M77.24M31.15M25.16M
Total Liabilities 172.96M178.64M181.20M249.78M237.12M238.99M239.63M264.74M263.58M228.15M233.25M206.38M117.11M71.94M66.80M
Shareholder's Equity
Common Equity 224.32M257.48M187.11M126.64M64.96M7.45M-50.84M-99.23M-98.31M-110.87M-90.54M-97.28M-55.07M-35.04M-36.63M
Shareholder's Equity 224.32M257.48M187.11M126.64M64.96M7.45M-50.84M-99.23M-98.31M-110.87M-90.54M-97.28M-55.07M-35.04M-36.63M
Liabilities and Shareholders Equity 397.28M436.12M368.32M376.42M302.08M246.44M188.79M165.50M165.27M117.28M142.71M109.10M62.04M36.90M30.17M
Retained Earnings -1552.83M-1534.36M-1618.45M-1693.02M-1767.80M-1838.90M-1908.70M-1969.15M-2000.90M-2019.95M-2041.86M-2054.55M-2016.54M-2014.16M-2018.46M
Treasury Shares 8.15M7.49M7.93M6.71M10.58M9.76M8.46M0.25M16.47M0.55M0.52M0.41M0.68M0.50M0.28M